Oral Answers to Questions Debate
Full Debate: Read Full DebateJacob Young
Main Page: Jacob Young (Conservative - Redcar)Department Debates - View all Jacob Young's debates with the Foreign, Commonwealth & Development Office
(3 years, 4 months ago)
Commons ChamberI thank the hon. Gentleman for giving us due notice that the support of the SNP for future trade arrangements cannot be guaranteed. I had kind of worked that out by myself, because over the past 15 years the SNP has never backed a trade agreement anywhere. There is, no doubt, always a reason for SNP Members to say no to trade agreements. To return to the broader point, our commitment to human rights is a foundation stone of our foreign policy and our “force for good” agenda in the world. We will ensure that we use our trade relationships not just to export products and services but to export our principles and values. He is right that that should be an inherent part of all trade agreements, and indeed it is, but ultimately, given that the SNP will be looking for an excuse to say no to a deal, he, I am sure, will always find one.
Through our investment in the development of the AstraZeneca vaccine, our finance for COVAX and our commitment of 100 million vaccine doses from surplus domestic supply, the UK is a global leader in our support for vaccinating the poorest around the world.
Lebanon has been hit by a succession of crises in recent months, not least the massive explosion in the port of Beirut last year, a deepening economic crisis, and rising political instability. Can the Foreign Secretary assure me that his Department is doing everything it can to support the people of Lebanon with their vaccine deployment so that Lebanese people do not have to endure shortages of covid-19 vaccines on top of the hardship that they are already enduring?
My hon. Friend is absolutely right. He will recall that, last year, as that terrible disaster took place, we committed $2 million in extra support for medical equipment. In relation to vaccines, in March, Lebanon received its first doses from COVAX: 33,600 AZ vaccines. The UK, through our £90 million commitment, got the AstraZeneca vaccine at cost price to the world, and the vast majority of COVAX doses—some 98%—that will have reached Lebanon have been the AZ vaccine. That demonstrates the value that the UK is providing not just with the domestic roll-out but abroad as well.